UNITED ~~STATES SECURITIES~~STATESSECURITIES AND EXCHANGE ~~COMMISSION Washington~~COMMISSIONWashington, D.C. ~~20549~~20549__________________

__________________

FORM 8-K

CURRENT ~~REPORT Pursuant~~REPORTPursuant to Section 13 OR 15(d) of ~~The~~the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~May~~ 19July 31, 2025

THE CLOROX COMPANY (Exact name of registrant as specified in its charter) __________________


Delaware	1-07151	31-0595760
(State or other jurisdiction of	(Commission File Number)	(I.R.S. Employer
incorporation)		Identification No.)

1221 Broadway, Oakland, California 94612-1888 (Address of principal executive offices) (Zip code)

(510) 271-7000 (Registrant's telephone number, including area code)

Not applicable (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ~~(see General Instruction A.2. below)~~:

☐[ ] Written communications pursuant to Rule 425 ~~under~~Under the Securities Act (17 CFR 230.425) ☐[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	~~Trading Symbol(s)~~	~~Name of each exchange on which registered~~	TradingSymbol(s)			Name of each exchange on which registered
Common Stock - $1.00 par value	~~CLX~~	~~New York Stock Exchange~~	CLX			New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

~~Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year~~1

~~The~~Item ~~Board of Directors of The Clorox Company (the “Company”) amended and restated the Company’s bylaws (the “Bylaws”), effective May 19, 2025~~2.02 ~~The~~Results amendments implement a cure process for certain deficiencies in director nomination notices submitted by shareholders. For nomination notices received by the Company within the time period specified in the Bylaws, the Company will notify shareholders of ~~deficiencies~~Operations ~~in the notice~~ and ~~there~~Financial ~~will be an opportunity to cure such deficiencies within the time period specified.~~Condition

~~This~~On ~~description~~July of31, ~~the~~2025, ~~amendments~~The toClorox ~~the~~Company ~~Bylaws~~issued isa ~~not~~press ~~complete~~release ~~and is~~announcing ~~qualified~~its infinancial results for its ~~entirety~~fourth byquarter ~~reference~~and tofiscal ~~the~~year ended June 30, 2025. The full text of the ~~Bylaws~~press ~~filed~~release is attached hereto as Exhibit 399.21 toand ~~this~~is ~~Report~~incorporated herein by reference.

Item 97.01 ~~Financial~~Regulation ~~Statements~~FD ~~and Exhibits~~Disclosure

~~(d)~~Attached ~~Exhibits~~hereto as Exhibit 99.2 and incorporated herein by reference is supplemental financial information.

~~See~~Item ~~the~~9.01 ~~Exhibit~~Financial ~~Index~~Statements ~~below.~~and Exhibits

~~EXHIBIT~~(d) ~~INDEX~~Exhibits

Exhibit		Description
3.2		Amended and Restated Bylaws
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

See the Exhibit Index below.

2 EXHIBIT INDEX

SIGNATURES


Exhibit						Description
99.1						Press Release dated July 3 1, 202 5 of The Clorox Company
99.2						Supplemental information regarding financial results
104						Cover Page Interactive Data File (embedded within the Inline XBRL document)

~~Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.~~2

		THE CLOROX COMPANY
Date:	May 23, 2025	By:	/s/ Angela Hilt
			Angela Hilt
			Executive Vice President – Chief Legal and External Affairs Officer and Corporate Secretary

SIGNATURES

3 Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


		THE CLOROX COMPANY


Date:	July 31, 2025	By:	/s/ Angela Hilt
			Angela Hilt
			Executive Vice President – Chief Legal and External Affairs Officer and Corporate Secretary

Filing Compare · CLOROX CO /DE/